Skip to Content
Find More Like This
Return to Search

FUNCTIONALIZED NANOMATERIALS FOR CHELATION THERAPIES AND SORBENT DIALYSIS OF TOXINS

United States Patent Application

20110110985
A1
View the Complete Application at the US Patent & Trademark Office
Pacific Northwest National Laboratory - Visit the Technology Commercialization Program Website
A therapy agent is disclosed that is made up of a functionalized nanomaterial that provides solutions to current problems facing the field of chelation therapies and dialysis of metals, radionuclides, and metabolic wastes. Through the coupling of groups tailored to selectively capture specific toxins and rigid porous backbone structures (e.g., mesoporous silica and mesoporous carbon), suitable materials that are highly effective and fast at capturing toxins (metals, radionuclides, and metabolic wastes) in the presence of competing ions and proteins. These materials may be embodied in a variety of treatment devices which allow for treatment and removal of these target materials through a variety of methodologies including oral, dermal and dialysis pathways.
Fryxell, Glen E. (Kennewick, WA), Timchalk, Charles (Kennewick, WA), Addleman, Raymond S. (Benton City, WA), Yantasee, Wassana (Richland, WA)
BATTELLE MEMORIAL INSTITUTE (Richland WA)
12/ 613,998
November 6, 2009
STATEMENT REGARDING RIGHTS TO INVENTION MADE UNDER FEDERALLY-SPONSORED RESEARCH AND DEVELOPMENT [0001] This invention was made with Government support under Contract DE-AC05-76RLO1830 awarded by the U.S. Department of Energy. The Government has certain rights in the invention.